chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Monday(Day of immunization)- generalized aches and headache in the afternoon. That evening- chills and fever and very restless all night. Tuesday morning- stiff neck, swollen and very tender lymph nodes under left arm(armpit). Lymph nodes behind left ear and down jawline enlarged and very tender. Lymph nodes along left clavicle swollen and hard, quarter sized, multiple sites (4). Injection area warm tp touch, red area at injection site  3x4 cm. Skin reddened on left side of face, felt sore also. Blurred vision and diarrhea later on Tuesday. Uncomfortable night sleeping , slept propped up on pillows. Wednesday-  entire left neck area swollen and tender. Lymph nodes along right clavicle swollen and tender to touch. Skin achy and very tender. Called my doctors office. Forced fluids, took tylenol and rested all afternoon and evening. Thursday morning- blurred vision lessened, skin tenderness diminished, lymph nodes hard and more defined on left clavicle. Base of head(neck region) still headache. Facial flushing left side decreased. Right clavicle lymph nodes less swollen but firm. Jawline and armpit less tender. Generalized malaise improving.Friday will be day 5
Tiredness; COVID-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 virus test positive) and FATIGUE (Tiredness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ankylosing spondylitis and Rheumatoid arthritis.    No Medical History information was reported.   In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On 04-Jan-2021, the patient experienced COVID-19 (COVID-19 virus test positive). On an unknown date, the patient experienced FATIGUE (Tiredness). At the time of the report, COVID-19 (COVID-19 virus test positive) was resolving and FATIGUE (Tiredness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jan-2021, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications were reported.  Patient received Humira (1158135).  No treatment medications were reported.  The reporter assessed the events as possibly related to Moderna vaccine.  The reporter did not provide any causality assessment for the event of tiredness with Humira. The reporter assessed the event of Covid-19 virus test positive as reasonably possible with Humira.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
At 1536, patient reported she felt "woozy" and had a "dry throat". RN assessed patient. Patient denied itchiness, rashes, difficulty swallowing, and difficulty breathing. Patient offered water and gatorade. Patient able to drink water and gatorade. Patient reported feeling "woozy" one hour after her first dose (VAERS: 637639). Patient reported she took Tylenol and symptom went away. Patient reported history of anemia, no current medications, and denied history of severe allergic reactions. At 1541, RN  assessed patient vital signs: blood pressure 156/100 mmHg, pulse 92 beats/minute and SpO2 98%. At 1550, RN  reassessed patient: blood pressure 150/98 mmHg, pulse 93 beats/minute, and SpO2 99%. Patient reported feeling "woozy" and feeling symptom "not as much". At 1601, RN reassessed patient vitals signs: blood pressure 136/100 mmHg, pulse 72 beats/minute, and SpO2 99%. Patient reported she felt "woozy" a "tiny bit but nothing terrible". Patient advised to wait for further observation. Patient denied advise and reported she was "okay" to drive. RN educated patient on signs/symptoms of when to seek emergency care, to follow up with primary care provider and to sign up on v-safe. At 1607, patient left facility with unlabored respirations and steady gait.
I got my 2nd dose of pfizer on Monday. By the end of the day I had started having a dark old blood looking discharge from my lvagina. It's still continuing as of now. Not much of a flow or color change. I had some cramping Monday, but that was it. I'm reporting this because it's VERY abnormal for me. I never missed a pill or took a pill late. I just had a period back in May, so it's not because I'm years over due. I never breakthrough bleed, and even when I did have to let myself start a period in May, it took several days for it to start producing anything. To the best of my knowledge I wasn't pregnant and am not pregnant. It's not producing enough to convince me that it could even be a very very early pregnancy miscarriage. So, my assumption is narrowed down to it being from the vaccination.
Swollen lymph nodes; Nausea; vomiting; lack of appetite for 11 days; This is a spontaneous report from a contactable other health professional (patient) via COVID-19 Vaccine Adverse Event Self-Reporting Solution. A 29-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, /Lot Number: EL9262, expiration date not reported), via an unspecified route of administration, administered in left arm on 24Jan2021 14:45 (age at the time of vaccination 29-year-old) as 1st dose, single for covid-19 immunisation at workplace clinic. Patient had no medical history. The patient concomitant medications received within 2 weeks of vaccination include multivitamins. The patient had no allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Jan2021, the patient experienced swollen lymph nodes, nausea, vomiting, lack of appetite for 11 days. It was unknown if the patient was pregnant. The patient underwent lab tests and procedures which included sars-cov-2 test, nasal swab with negative result on 31Jan2021. The case was considered as non-serious with no seriousness criteria (Results in death/ Life threatening/Caused/prolonged hospitalization/Disabling/Incapacitating/ Congenital anomaly/birth defect). The patient did not receive any treatment for the events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a Bachelor of Science in Nursing (B.S.N) via Pfizer (manufacturer control #2015383080), concerning a patient of unknown age and gender. The patient's pertinent medical history or concurrent conditions were not provided. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23, (route, dose, anatomical location, lot/batch # were not reported). Co-suspect therapies or concomitant medications were not provided. On an unknown date, the patient experienced severe local reaction reported as large welts and rash to PNEUMOVAX 23. The outcome of urticaria was unknown. The reporter considered urticaria to be related to PNEUMOVAX 23. Additional information has been requested.
Urticaria with very faint pinkness. (L) leg, pain with movement of raising arm (L) upper arm shoulder same arm as injection. Pruritis (L) arm, abdomen and (L) leg after appt. tx with Benadryl
Pt had a fever of 103F, face swelled on right side of face, and right eye swelled shut. Mom called health dept. Benadryl given.
Severe pain in injection site; do not feel well; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 at 11:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and back pain. Patient previously took ibuprofen (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications included paracetamol (TYLENOL), menthol; capsaicin (ALLEVESS) and calcium carbonate; magnesium carbonate (TUMS); all for an unknown indication from an unknown start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 15Apr2021, the patient experienced severe pain in injection site and did not feel well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the event severe pain in injection site and do not feel well was unknown at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Pt developed a rash on her left arm where the varicella vaccine was received. No fever, sweats, chills, vomiting or diarrhea.
This spontaneous report was received from a Licensed Practical Nurse referring to unspecified patients of unknown age and gender. There was no information about the patient's concurrent conditions or medical history. The patient's concomitant therapies included sterile diluent. On an unknown date, the patients were vaccinated with an improperly stored doses of VAQTA lot numbers: R006210/R006209, expiration dates: 22-APR-2019/16-MAR-2019 respectively; ROTATEQ lot numbers: N030152/ R003114, expiration dates: 01-SEP-2019/27-SEP-2019 respectively; RECOMBIVAX HB lot numbers: R006746/ R004185, expiration dates: 09-NOV-2020/06-NOV-2020 respectively and M-M-R II lot number: N025892, expiration date: 19-SEP-2019 (dosage schedule, route and anatomical location were not reported for all the vaccines) for prophylaxis. There was no adverse effect reported. The administered doses of vaccines experienced the temperature excursion of 11.5 degrees Celsius for 1 hour 46 minutes. The previous temperature excursion was not reported. Data logger was involved
Patient got his vaccine at 10:48. By 11:03, he as white as a ghost. He passed out upright in his chair. When he came back round seconds later, he was white a ghost. He started vomiting. He reported he lost vision and had ringing in his ears before he went out. His BP was 80/55 with a pulse of 64. He said he has had issues with needles entering his skin. By 11:20am, he was resting on the bed. HR 57, Oxygen 99, and bp was 120/68.
COLD INTOLLERANCE SINCE RETURNING FROM MY TRIPE. I RECIEVED MULTIPLE VACCINES WITHIN A SHORT PERIOD OF THE BOOSTER VACCINE. S/S ARE HIVES WITH ITCHYNESS ALL OVER  WHEN TEMPRATURE DROP.  Rash still occurs.
Patient left on the bandaid that had been applied at time of vaccine for over a week. Patient's wife noticed a small sore on the upper arm of patient during the weekend. Approximately half an inch wet sore with some reddness on upper left arm viewed by two pharmacists at this location on Monday. Advised patient to apply neosporin twice daily and replace bandaid at each application.
some of the vaccine leaked out and only got about 0.3 ml dose; A spontaneous report  was received from a nurse concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and some of the vaccine leaked out and she estimates she only got about 0.3 ml dose.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On an unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   Nurse called to report she had a patient who received the mRNA-1273 vaccine and stated some of the vaccine leaked out and she estimated she only got about a 0.3 mL dose. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not provided.   The event, some of the vaccine leaked out and she estimates she only got about 0.3 ml dose, was considered resolved.; Reporter's Comments: This case concerns a female patient of unreported age. The patient's medical history is not provided. The patient experienced an unexpected event of incomplete dose administered as some vaccine leaked out (only about 0.3ml dose given to patient). The event occurred on an unknown date during administration of the first dose of mRNA-1273. The sponsor considered the event as not related to mRNA-1273.
Cellulitis left arm. Left arm redness from deltoid to elbow, warm to touch. No fever.
Patient reported within 24 hours of receiving vaccine a fainting episode, estimated to last approximately one minute. It occurred when she got up from a sitting position to a standing one. After the event she got up on her own. She also experienced chills in the middle of the night. Additionally, she felt dizzy and fatigued. These symptoms resolved within 24 hours. She did not report this to her health care providers at the time.
herpes zoster; Information has been received regarding a case in litigation from a lawyer, and a  female patient of unknown age, and her spouse. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 08-AUG-2008, at age 70, the patient was administered the zoster vaccine live (ZOSTAVAX) by a pharmacist (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician for the following injury resulting from her zoster vaccine live (ZOSTAVAX) use: Herpes zoster. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the Herpes zoster is unknown.  Additional information has been requested.
Swelling and pain in arm just distal to injection unable to move arm for 2 days due to pain. Swelling and pain slowly resolving without treatment. pt has rheumatoid arthritis.
Splitting ache left side; left ear ache-very strong.  Left neck in a lot of pain, unable to bend down to accomplish tasks.  Constant pounding  in ear, ringing/roaring.  Cannot hear in left ear, very low volume; right ear also effected but a little better in hearing.  Constant pounding in ears.  Pain still continues in left ear.
This spontaneous report was received from a medical assistant, concerning a patient of an unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 01-MAY-2017, the patient was vaccinated with an improperly stored dose of ROTATEQ with lot # M025568 and expiration date on 07-NOV-2017 (strength and dose were not reported) for prophylaxis. The storage temperature was reported as 47 to 77 degrees Fahrenheit (°F) for a time frame of 7 hours and 15 minutes; but there was a previous temperature excursion reported, with a temperature of 32°F to 35°F for 10 hours. This is one of several reports received from the same source. No product quality complaint (PQC) was involved. Additional information has been requested.; Sender's Comments: US-009507513-1706USA002269: US-009507513-1706USA002268: US-009507513-1706USA002266: US-009507513-1706USA002267:
mom phoned pt had red blotchy areas on neck & chest; also had some wheezing; instructed mom to call MD immediately & take pt to ER: had swelling of face & lips;
left side neck and shoulder pain; left side neck and shoulder pain; back and inner left arm muscle pain; back and inner left arm muscle pain; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3302), via an unspecified route of administration in right arm on 28Feb2021 16:30 (at the age of 75-years-old) as dose 1, single for COVID-19 immunization. Medical history included Penicillin allergy and Graves' disease. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any vaccines within four weeks. The patient's concomitant medications were not reported. The patient experienced left side neck and shoulder pain, back and inner left arm muscle pain on an unspecified date. Since the vaccination, patient has not been tested for COVID-19. No treatment was received for the event. Outcome of events was not resolved.  No follow-up attempts are possible. No further information is expected.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 65 or 66 years. The patient experienced sore arm after receiving 1st dose of Shingrix. Consent to follow up was provided. For tolerance with 2nd dose of Shingrix refer case US2020AMR012880. The patient did not experienced rash (which was red bumps) after 1st dose of Shingrix.
RASH NOTED AFTER VACCINATIONS IN LOWER LEFT ARM UNDER SHOT GIVEN. RASH CONTINUED TO GET WORSE. PT DAUGHTER CALLED PHARMACY TO ASK ADVICE AND WAS TOLD TO GO HAVE HER PHYSICIAN EXAM HER TODAY (CALL WAS EARLY AFTERNOON BEFORE MD OFFICE CLOSED).
itchy throat and difficulty swallowing  less than 24 hours after vaccine given  self treated with Benadryl symptoms resolved
My 1 year old son received the MMRV on 4/25/07. He appears to have gotten chicken pox from the vaccine. He had had fevers and is broken out in blisters from head to toe!
pt recv vax & devel swelling @ the inj site;no further info was available @ the date of this report;
Information has been received from a registered nurse (RN) concerning a 9 year old male with a concurrent condition of attention Deficit Hyperactivity Disorder (ADHD), with no reported drug reaction or allergies, who on 24-November-1998 was vaccinated with a first 0.5 ml dose intramuscularly with Varivax (Lot Number 626959/0846H). Concomitant therapy that day included a first MMR II, which was also administered on 24-November-1998, and dexmethylphenidate hydrochloride (FOCALIN) and atomoxetine hydrochloride (STRATTERA). On 21-February-2007, the patient developed chickenpox, including red lesions on the chest and back, along with a temperature of 101 F. The patient's was not recovered at the time of this report. Unspecified medical attention was sought. Follow up information indicated that on 21-FEB-2007 the patient developed red lesions on his chest and back for one week. There were scabbing over and his skin was sensitive and itching. He was treated with acyclovir 400mg TID. The outcome was recovered. The reporter considered the event to be an other important medical event. There was no product quality complaint. No additional information is expected.
I was very sick in bed for 6 days with symptoms just like I had with Covid . After over spitting up bright red blood.
Chest pain and shortness of breathe during the first episode 3 weeks after the 2nd vaccine. Then another episode of severe chest pain, shortness of breath, and tachycardia. Diagnosed with Pericarditis and pericardial effusion. Was given Colchicine for 30 days and IV Toradol for pain in the ER.
Fatigued, strong dull headache and body ache from Sunday afternoon until Tuesday afternoon,  flu like symptoms without the fever. Injection arm slightly sore, 1st injection much more sore than 2nd. Took (2) each 200mg  ibuprofen every 4-6 hours through Wednesday afternoon.
Persistent Dysgeusia and Parosmia occuring 3 days post 2nd vaccine Pfizer (June 5th, 2021: EW0185, first dose 5/15/21- EW0171 ).  I cannot eat about 80% of foods due to disgusting smell and taste.  This includes all food with animal proteins (meat, fish, chicken, eggs) plus food containing corn products as examples.  I spend 90% of my day with a horrible taste in my mouth. I had not been exposed to anyone with Covid during this time nor to my knowledge to date.
Patient immediately lost consciousness and became incontinent regained consciousness after 5 minutes but was groggy. Able to sit up/walk after 20 minutes. No history of seizures. Had symptoms for treatment 3 years ago with no further treatment.
PATIENT SHOULD HAVE RECEIVED FIRST DOSE IN PRIMARY SERIES AND INSTEAD GOT BIVALENT BOOSTER OF PFIZER
Initial reaction severe pain for 24 hrs at injection site.  Today, I notices a red raised swelling. Warm to the touch and itchy.
Wrong Vaccine Administered; Administered to an elven year old child; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old male patient who received DTPa (Infanrix) (batch number 49tm3, expiry date 28th May 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 18th December 2020, the patient received Infanrix (intramuscular) and Infanrix Pre-Filled Syringe Device. On 18th December 2020, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The physician called to report wrong vaccine administered to a 11 years old patient with Infanrix vaccine, which led to inappropriate age at vaccine administered and wrong vaccine administered. The reporter consented to follow up.
Fever 102.5 to 103.7 R. Rash lower torso area. Fever broke 3/27/03 3pm, 3/28/03 measles all gone except 2 or three little red dots.
AFTER RECEIVING 1ST GARDASIL VACCINE, PT AND MOTHER RETURNED TO CHECK-OUT WINDOW AND STATED THE PT "COULDN'T SEE." PT BROUGHT BACK TO TRIAGE ROOM WHERE SHE WAS VERY COOL, CLAMMY, AND LETHARGIC. SHE WAS TAKEN BACK TO EXAM ROOM AND WAS BEING HELPED UP ON TABLE WHEN SHE PASSED OUT. PT DID NOT FALL SINCE NURSE AND MOTHER WERE ASSISTING HER. PHYSICIAN MADE AWARE AND WENT TO EXAMINE PT. SHE SOON AWOKE WHILE HE WAS PERFORMING ASSESSMENT. PT RESTED FOR 15 MINS AND WAS ABLE TO WALK AROUND IN HALLWAY BEFORE LEAVING BUILDING.
Following morning a sore throat leading two days later an inability to swallow, constant mucus production, several boxes of tissues dsily; hospitalized for 4 days on intravenous  fluids and anti biotics.
Onset of cellulitis/erythematous and induration within 12 to 24 hours, post vax. Fever to 100F, 24 hours, post vax with erythema, pain and induration increased to triple size within 48 hours, post vax. Dx'd with cellulitis. Treated with Keflex X 7 days.